AR and neoplasm: Therefore, the altered sensitivity of TNBC cells to EGFR and AR antagonists due to hypoxia induced AnxA6 expression provides a rationale for further studies on the response of molecularly distinct TNBCs to various therapies and/or in rapidly growing and necrotic tumors in which hypoxia is a key factor in the tumor microenvironment.